Aeovian Pharmaceuticals Company
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Founded Date:
2012
Total Funding:
37000000
Investor Type:
Early Stage Venture
Employee Number:
1-10
Funding Status:
Early Stage Venture
Number Of Exists:
Series A
Technology:
NeuroTech
Last Funding Type:
Series A
Investors Number:
4
Last Funding Date:
2019
Industry:
Biopharma, Biotechnology, Health Care, Pharmaceutical
Headquarters:
San Francisco, California, United States
Estimated Revenue:
$1M to $10M